ADOCIA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.44 EUR | -3.72% |
|
-23.27% | -52.86% |
| Jul. 11 | ADOCIA : price target reduced by Oddo BHF | CF |
| Jul. 10 | Adocia, Tonghua Dongbao End Insulin Combo License Deal | MT |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 68.66 | 57.65 | 58.24 | 33.82 | 162.1 | 81.82 | - | - |
| Enterprise Value (EV) 1 | 46.15 | 57.73 | 77.56 | 33.82 | 162.3 | 71.02 | 45.42 | 28.92 |
| P/E ratio | -3.67 x | -2.52 x | -2.53 x | -4.41 x | -6.07 x | 2.67 x | 1.57 x | 2.57 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 8.44 x | 8.44 x | 9.62 x | 1.95 x | 26.8 x | 2.01 x | 1.22 x | 0.78 x |
| EV / Revenue | 5.67 x | 8.45 x | 12.8 x | 1.95 x | 26.8 x | 1.75 x | 0.68 x | 0.28 x |
| EV / EBITDA | -2.21 x | -2.88 x | - | - | -11.8 x | 4.47 x | 1.98 x | 1.31 x |
| EV / FCF | -3.95 x | -2.62 x | -3.96 x | - | -31.8 x | 6.52 x | 1.77 x | 1.75 x |
| FCF Yield | -25.3% | -38.2% | -25.3% | - | -3.15% | 15.3% | 56.4% | 57% |
| Price to Book | 2.46 x | 9.14 x | - | - | -23.5 x | 7.88 x | 1.86 x | 1.27 x |
| Nbr of stocks (in thousands) | 6,935 | 6,946 | 7,190 | 8,519 | 14,050 | 15,041 | - | - |
| Reference price 2 | 9.900 | 8.300 | 8.100 | 3.970 | 11.54 | 5.440 | 5.440 | 5.440 |
| Announcement Date | 3/12/20 | 3/18/21 | 4/19/22 | 3/15/23 | 4/24/24 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 8.134 | 6.833 | 6.055 | 17.36 | 6.048 | 40.7 | 67 | 105 |
| EBITDA 1 | -20.86 | -20.02 | - | - | -13.74 | 15.9 | 22.9 | 22.1 |
| EBIT 1 | -22.02 | -21.15 | -19.37 | -12.9 | -14.24 | 14.3 | 20.2 | 17.9 |
| Operating Margin | -270.73% | -309.5% | -319.83% | -74.28% | -235.52% | 35.14% | 30.15% | 17.05% |
| Earnings before Tax (EBT) | - | -23.3 | -22.75 | -6.425 | - | - | - | - |
| Net income 1 | -18.6 | -23.32 | -22.75 | -6.901 | -21.16 | 14.6 | 24.8 | 15.2 |
| Net margin | -228.71% | -341.34% | -375.79% | -39.75% | -349.9% | 35.87% | 37.01% | 14.48% |
| EPS 2 | -2.700 | -3.300 | -3.200 | -0.9000 | -1.900 | 2.040 | 3.460 | 2.120 |
| Free Cash Flow 1 | -11.67 | -22.06 | -19.6 | - | -5.106 | 10.9 | 25.6 | 16.5 |
| FCF margin | -143.52% | -322.83% | -323.62% | - | -84.42% | 26.78% | 38.21% | 15.71% |
| FCF Conversion (EBITDA) | - | - | - | - | - | 68.55% | 111.79% | 74.66% |
| FCF Conversion (Net income) | - | - | - | - | - | 74.66% | 103.23% | 108.55% |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 3/12/20 | 3/18/21 | 4/19/22 | 3/15/23 | 4/24/24 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2020 S2 | 2021 S1 | 2021 Q3 | 2021 Q4 | 2022 S1 | 2022 S2 |
|---|---|---|---|---|---|---|
| Net sales | 3.261 | 0.402 | 1.76 | - | 7.349 | 10.01 |
| EBITDA | - | - | - | - | - | - |
| EBIT 1 | - | - | -4.86 | -4.86 | - | - |
| Operating Margin | - | - | -276.14% | - | - | - |
| Earnings before Tax (EBT) 1 | - | - | -6.08 | -6.08 | - | - |
| Net income 1 | - | - | -6.08 | -6.08 | 4.252 | - |
| Net margin | - | - | -345.45% | - | 57.86% | - |
| EPS | - | - | -0.8600 | - | - | -1.400 |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 3/18/21 | 7/22/21 | 4/27/22 | 4/19/22 | 9/19/22 | 3/15/23 |
1EUR in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | 0.08 | 19.3 | - | 0.13 | - | - | - |
| Net Cash position 1 | 22.5 | - | - | - | - | 10.8 | 36.4 | 52.9 |
| Leverage (Debt/EBITDA) | - | -0.003997 x | - | - | -0.009246 x | - | - | - |
| Free Cash Flow 1 | -11.7 | -22.1 | -19.6 | - | -5.11 | 10.9 | 25.6 | 16.5 |
| ROE (net income / shareholders' equity) | -50.4% | -136% | - | - | - | - | - | 37.9% |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share 2 | 4.030 | 0.9100 | - | - | -0.4900 | 0.6900 | 2.930 | 4.300 |
| Cash Flow per Share | - | - | - | - | - | - | - | - |
| Capex 1 | 2.02 | 0.21 | 0.36 | - | 0.16 | 0.8 | 1.3 | 2.1 |
| Capex / Sales | 24.82% | 3% | 5.96% | - | 2.58% | 1.97% | 1.94% | 2% |
| Announcement Date | 3/12/20 | 3/18/21 | 4/19/22 | 3/15/23 | 4/24/24 | - | - | - |
1EUR in Million2EUR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
5.44
EUR
Average target price
6.3
EUR
Spread / Average Target
+15.81%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -52.86% | 89.23M | |
| +20.12% | 126B | |
| +25.25% | 119B | |
| +25.56% | 27.95B | |
| -19.51% | 20.5B | |
| -14.36% | 17.12B | |
| -15.63% | 16.1B | |
| -46.67% | 14.97B | |
| +11.89% | 14.84B | |
| +57.74% | 14.38B |
- Stock Market
- Equities
- ADOC Stock
- Financials Adocia
